Adolescent Self-Efficacy in Relation to Illness Perception and Treatment Compliance: An Inpatient Study

Ancel Andrew George; Anneke Louise Franken

doi:10.25159/2708-9355/11130

Authors

Ancel Andrew George University of the Free State
Anneke Louise Franken University of the Free State

DOI:

https://doi.org/10.25159/2708-9355/11130

Keywords:

treatment compliance, psychotropic treatment, illness perception, self-efficacy, adolescents

Abstract

Non-compliance with psychotropic treatment appears to be a growing problem among adolescent mental healthcare users. Treatment is frequently initiated during hospitalisation periods; however, at discharge a change in the primary administrator of the treatment poses a risk that the discharged patient may become non-compliant. In this study, we investigate factors influencing psychotropic treatment compliance of adolescent inpatients admitted to a psychiatric facility. A quantitative, non-experimental, cross-sectional, survey-type research design was employed. Approximately 170 participants were selected through a non-probability convenience sampling method. The data were gathered using self-reporting measures, namely the Drug Attitude Inventory, the Brief Illness Perception Questionnaire and the Decision Self-Efficacy Scale. The data were analysed using a Pearson product–moment correlation coefficient and a moderated hierarchical regression analysis. The results indicated a significant relationship between illness perception and self-efficacy where self-efficacy was identified as a moderator between illness perception and treatment compliance of male adolescent inpatients. The findings of the study and the gender differences which surfaced may contribute to a better understanding of the intricate processes related to treatment compliance in adolescents. These findings may help to direct intervention aimed at promoting treatment compliance.

Metrics

Metrics Loading ...

References

AACAP (American Academy of Child and Adolescent Psychiatry). 2012. “A Guide for Public Child Serving Agencies on Psychotropic Medications for Children and Adolescents.” Accessed 10 January 2022. http://www.aacap.org/App_Themes/AACAP/docs/press/guide_for_community_child_serving_agencies_on_psychotropic_medications_for_children_and_adolescents_2012.pdf.

Acar, G., K. Bademli, and N. Lök. 2017. “Medication Non-Adherence in Chronic Mental Illness: Management Strategies.” ARC Journal of Psychiatry 2 (1): 23–25.

APA. 2013. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th ed. Washington: APA.

Atorkey, P., P. N. Doku, S. A. Danquah, C. Owiredua, and M. Akwei. 2017. “Illness Perceptions and Medication Adherence in Adolescents with Sickle Cell Disease in Two Selected Hospitals in Greater Accra.” IFE Psychologia 25 (2): 180–94.

Averous, P., E. Charbonnier, M. C. Lagouanelle-Simeoni, A. Prosperi, and L. Dany. 2018. “Illness Perceptions and Adherence in Bipolar Disorder: An Exploratory Study.” Comprehensive Psychiatry 80: 109–15. https://doi.org/10.1016/j.comppsych.2017.10.003. DOI: https://doi.org/10.1016/j.comppsych.2017.10.003

Bandura, A. 2004. “Health Promotion by Social Cognitive Means.” Health Education and Behavior 31 (2): 143–64. https://doi.org/10.1177/1090198104263660. DOI: https://doi.org/10.1177/1090198104263660

Bikaako-Kajura, W., E. Luyirika, D. W. Purcell, J. Downing, F. Kaharuza, J. Mermin, S. Malamba, and R. Bunnell. 2006. “Disclosure of HIV Status and Adherence to Daily Drug Regimens among HIV-Infected Children in Uganda.” AIDS and Behavior 10 (4): S85–S93. https://doi.org/10.1007/s10461-006-9141-3. DOI: https://doi.org/10.1007/s10461-006-9141-3

Bobier, C., and M. Warwick. 2005. “Factors Associated with Readmission to Adolescent Psychiatric Care.” Australian and New Zealand Journal of Psychiatry 39: 600–6. https://doi.org/10.1080/j.1440-1614.2005.01632.x. DOI: https://doi.org/10.1080/j.1440-1614.2005.01632.x

Broadbent, E. n.d. “Scoring the Brief – IPQ.” https://www.uib.no/ipq/index.html.

Broadbent, E., K. J. Petrie, J. Main, and J. Weinman. 2006. “The Brief Illness Perception Questionnaire.” Journal of Psychosomatic Research 60: 631–7. https://doi.org/10.1016/j.jpsychores.2005.10.020. DOI: https://doi.org/10.1016/j.jpsychores.2005.10.020

Broadbent, E., C. Wilkes, H. Koschwanez, J. Weinman, S. Norton, and K. J. Petrie. 2015. “A Systematic Review and Meta-Analysis of the Brief Illness Perception Questionnaire.” Psychology & Health 30 (11): 1361–85. https://doi.org/10.1080/08870446.2015.1070851. DOI: https://doi.org/10.1080/08870446.2015.1070851

Bulloch, A. M., and S. B. Patten. 2010. “Non-Adherence with Psychotropic Medications in the General Population.” Social Psychiatry & Psychiatric Epidemiology 45 (1): 47–56. https://doi.org/10.1007/s00127-009-0041-5. DOI: https://doi.org/10.1007/s00127-009-0041-5

Bunn, H., and A. M. O’Connor. 1996. “Validation of Client Decision-Making Instruments in the Context of Psychiatry.” Canadian Journal of Nursing Research 28: 13–27. http://cjnr.archive.mcgill.ca/article/view/1344/1344.

Casey, B. J., R. M. Jones, and T. A. Hare. 2008. “The Adolescent Brain.” Annals of the New York Academy of Sciences 1124: 111–126. https://doi.org/10.1196/annals.1440.010. DOI: https://doi.org/10.1196/annals.1440.010

Chapman, S. E., and R. Horne. 2013. “Medication Nonadherence and Psychiatry.” Current Opinion in Psychiatry 26 (5): 446–52. https://doi.org/10.1097/YCO.0b013e3283642da4. DOI: https://doi.org/10.1097/YCO.0b013e3283642da4

Charach, A., T. Volpe, K. M. Boydell, and R. E. Gearing. 2008. “A Theoretical Approach to Medication Adherence for Children and Youth with Psychiatric Disorders.” Harvard Review of Psychiatry 16 (2): 126–35. https://doi.org/10.1080/10673220802069715. DOI: https://doi.org/10.1080/10673220802069715

De las Cuevas, C., and W. Peñate. 2014. “To What Extent Psychiatric Patients Feel Involved in Decision Making About Their Mental Health Care? Relationships with Socio-Demographic, Clinical, and Psychological Variables.” Acta Neuropsychiatrica 26 (6): 372–81. https://doi.org/10.1017/neu.2014.21. DOI: https://doi.org/10.1017/neu.2014.21

Dean, A. J., J. Walters, and A. Hall. 2010. “A Systematic Review of Interventions to Enhance Medication Adherence in Children and Adolescents with Chronic Illness.” Archives of Disease in Childhood 95 (9): 717–23. https://doi.org/101136/adc.2009.175125. DOI: https://doi.org/10.1136/adc.2009.175125

DiBonaventura, M., S. Gabriel, L. Dupclay, S. Gupta, and E. Kim. 2012. “A Patient Perspective of the Impact of Medication Side Effects on Adherence: Results of a Cross-Sectional Nationwide Survey of Patients with Schizophrenia.” BMC Psychiatry 12 (20): 1–7. https://doi.org/10.1186/1471-244X-12-2. DOI: https://doi.org/10.1186/1471-244X-12-20

Dilallo, J. J., and G. Weiss. 2009. “Motivational Interviewing and Adolescent Psychopharmacology.” Journal of American Academy of Child and Adolescent Psychiatry 48 (2): 108–13. https://doi.org/10.1097/CHI.0b013e3181930660. DOI: https://doi.org/10.1097/CHI.0b013e3181930660

Dixon, L. B., Y. Holoshitz, and I. Nossel. 2016. “Treatment Engagement of Individuals Experiencing Mental Illness: Review and Update.” World Psychiatry 15 (1): 13–20. https://doi.org/10.1002/wps.20306. DOI: https://doi.org/10.1002/wps.20306

Farooq, S., and F. Naeem. 2014. “Tackling Nonadherence in Psychiatric Disorders: Current Opinion.” Neuropsychiatric Disease and Treatment 10: 1069–77. https://doi.org/10.2147/NDT.S40777. DOI: https://doi.org/10.2147/NDT.S40777

Flisher, A. J., and A. Gevers. 2010. “Mental Health and Risk Behaviour.” In South African Child Gauge 2009/2010, edited by M. Kibel, L. Lake, S. Pendlebury and C. Smith, 53–57. Cape Town: Children’s Institute.

Floersch, J., L. Townsend, J. Longhofer, M. Munson, V. Winbush, D. Kranke, R. Faber, J. Thomas, H. Janis, R. Jenkins, and R. L. Findling. 2009. “Adolescent Experience of Psychotropic Treatment.” Transcultural Psychiatry 46 (1): 157–79. https://doi.org/10.1177/1363461509102292. DOI: https://doi.org/10.1177/1363461509102292

Fontanella, C. A. 2008. “The Influence of Clinical, Treatment, and Healthcare System Characteristics on Psychiatric Readmission of Adolescents.” American Journal of Orthopsychiatry 78 (2): 187–98. https://doi.org/10.1037/a0012557. DOI: https://doi.org/10.1037/a0012557

Frank, M. R., E. M. Heiby, and J. H. Lee. 2007. “Assessment of Determinants of Compliance to Twelve Health Behaviors: Psychometric Evaluation of the Health Behavior Schedule II.” Psychological Reports 100 (3): 1281–97. https://doi.org/10.2466/pr0.100.4.1281-1297. DOI: https://doi.org/10.2466/pr0.100.4.1281-1297

Garrido, P., and C. Saraiva. 2012. “Understanding the Revolving Door Syndrome.” European Psychiatry 27: 1. https://doi.org/10.1016/S0924-9338(12)74768-5. DOI: https://doi.org/10.1016/S0924-9338(12)74768-5

Hagell, A., J. Coleman, and F. Brooks. 2015. Key Data on Adolescence. London: Association for Young People’s Health.

Hamrin, V., E. M. McCarthy, and V. Tyson. 2010. “Pediatric Psychotropic Medication Initiation and Adherence: A Literature Review Based on Social Exchange Theory.” Journal of Child and Adolescent Psychiatric Nursing 23 (5): 151–72. https://doi.org/10.1111/j.1744-6171.2010.00237.x. DOI: https://doi.org/10.1111/j.1744-6171.2010.00237.x

Hodes, R., L. Cluver, P. Barron, N. R. Dlamini, L. Madisha, N. Mazibuko, H. Q. Nenzhelele, F. M. Motshwane, Y. Pillay, L. Kamugisha, and L. Schultz. 2017. National Adolescent and Youth Health Policy. National Department of Health. http://aviwe.wrhi.ac.za/national-adolescent-youth-health-policy-2017/.

Hogan, T. P., A. G. Awad, and R. Eastwood. 1983. “A Self-Report Scale Predictive of Drug Compliance in Schizophrenics: Reliability and Discriminative Validity.” Psychological Medicine 13: 177–83. https://doi.org/10.1017/S0033291700050182. DOI: https://doi.org/10.1017/S0033291700050182

Huefner, J. C., and A. K. Grifﬁth. 2014. “Psychotropic Medication Use with Troubled Children and Youth.” Journal of Child and Family Studies 23: 613–6. https://doi.org/10.1007/s10826-014-9941-4. DOI: https://doi.org/10.1007/s10826-014-9941-4

Imran, N., M. W. Azeem, M. R. Chaudhry, and Z. Butt. 2015. “Illness Perceptions in Adolescents with a Psychiatric Diagnosis in Pakistan.” BJPsych Bulletin 39 (4): 174–8. https://doi.org/10.1192/pb.bp.114.04829. DOI: https://doi.org/10.1192/pb.bp.114.048298

James, J. 2013. “Health Policy Brief: Patient Engagement.” Health Affairs 1–6. https://doi.org/10.1377/hpb20130214.898775. DOI: https://doi.org/10.1377/hpb20130214.898775

Jensen, P. S., J. Buitelaar, G. J. Pandina, C. Binder, and M. Haas. 2007. “Management of Psychiatric Disorders in Children and Adolescents with Atypical Antipsychotics: A Systematic Review of Published Clinical Trials.” European Child and Adolescent Psychiatry 16: 104–20. https://doi.org/10.1007/s00787-006-0580-1. DOI: https://doi.org/10.1007/s00787-006-0580-1

Jin, J., G. E. Sklar, V. M. Oh, and S. C. Li. 2008. “Factors Affecting Therapeutic Compliance: A Review from the Patients’ Perspective.” Therapeutic and Clinical Risk Management 4: 269–86. DOI: https://doi.org/10.2147/TCRM.S1458

Kampman, O., K. Lehtinen, V. Lassila, E. Leinonen, O. Poutanen, and A. M. Koivisto. 2000. “Attitudes Towards Neuroleptic Treatment: Reliability and Validity of the Attitudes towards Neuroleptic Treatment (ANT) Questionnaire.” Schizophrenic Research 45: 223–34. https://doi.org/10.1016/S0920-9964(99)00204-2. DOI: https://doi.org/10.1016/S0920-9964(99)00204-2

Knapp, P., D. K. Raynor, J. E. Thistlethwaite, and M. B. Jones. 2009. “A Questionnaire to Measure Health Practitioners’ Attitudes to Partnership in Medicine Taking: LATCon II.” Health Expectations 12 (2): 175–86. https://doi.org/10.1111/j.1369-7625.2009. DOI: https://doi.org/10.1111/j.1369-7625.2009.00545.x

Kapphahn, C., M. Morreale, V. Rickert, and L. Walker. 2006. “Financing Mental Health Services for Adolescents: A Position Paper of the Society for Adolescent Medicine.” Journal of Adolescent Health 39: 456–8. https://doi.org/10.1016/j.jadohealth.2005.12.013. DOI: https://doi.org/10.1016/j.jadohealth.2005.12.013

Laurier, C., D. Lafortune, and J. Collin. 2010. “Compliance with Psychotropic Medication Treatment among Adolescents Living in Youth Care Centres.” Children and Youth Services Review 32: 67–73. https://doi.org/10.1016/j.childyouth.2009.07.007. DOI: https://doi.org/10.1016/j.childyouth.2009.07.007

Longhofer, J., and J. Floersch. 2010. “Desire and Disappointment: Adolescent Psychotropic Treatment and Adherence.” Anthropology & Medicine 17 (2): 159–72. https://doi.org/10.1080/13648470.2010.493599. DOI: https://doi.org/10.1080/13648470.2010.493599

Maree, K., J. W. Creswell, L. Ebersohn, I. Eloff, R. Ferreira, N. V. Ivankova, J. D. Jansen, J. Pietersen, V. L. Plano Clark, and C. van der Westhuizen. 2013. First Steps in Research. Pretoria: Van Schaik.

Martin, L. R., S. L. Williams, K. B. Haskard, and M. R. DiMatteo. 2005. “The Challenge of Patient Adherence.” Therapeutics and Clinical Risk Management 1 (3): 189–99. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1661624/pdf/tcrm0103-189.pdf.

Moeini, B., F. Shafii, A. Hidarnia, G. R. Babaii, B. Birashk, and H. Allahverdipour. 2008. “Perceived Stress, Self-Efficacy and Its Relations to Psychological Well-Being Status in Iranian Male High School Students.” Social Behavior and Personality: An International Journal 36 (2): 257–66. https://doi.org.10.2224/sbp.2008.36.2.257. DOI: https://doi.org/10.2224/sbp.2008.36.2.257

Molteni, S., G. Giaroli, G. Rossi, M. Comelli, M. Rajendraprasad, and U. Balottin. 2014. “Drug Attitude in Adolescents: A Key Factor for a Comprehensive Assessment.” Journal of Clinical Psychopharmacology 34: 99–108. https://doi.org/10.1097/JCP.0000000000000035. DOI: https://doi.org/10.1097/JCP.0000000000000035

Moncrieff, J., K. Azam, S. Johnson, L. Marston, N. Morant, K. Darton, and N. Wood. 2016. “Results of a Pilot Cluster Randomised Trial of the Use of a Medication Review Tool for People Taking Antipsychotic Medication.” BMC Psychiatry 16 (1): 205. https://doi.org/10.1186/s12888-016-0921-7. DOI: https://doi.org/10.1186/s12888-016-0921-7

Moses, T. 2011. “Adolescents’ Commitment to Continuing Psychotropic Medication: A Preliminary Investigation of Considerations, Contradictions, and Correlates.” Child Psychiatry and Human Development 42: 93–117. https://doi.org/10.1007/s10578-010-0209-y. DOI: https://doi.org/10.1007/s10578-010-0209-y

Munson, M., J. Floersch, and L. Townsend. 2009. “Attitudes Toward Mental Health Services and Illness Perceptions Among Adolescents with Mood Disorders.” Child & Adolescent Social Work Journal 26 (5): 447–66. https://doi.org/10.1007/s10560-009-0174-0. DOI: https://doi.org/10.1007/s10560-009-0174-0

Nagae, M., H. Nakane, S. Honda, H. Ozawa, and H. Hanada. 2015. “Factors Affecting Medication Adherence in Children Receiving Outpatient Pharmacotherapy and Parental Adherence.” Journal of Child and Adolescent Psychiatric Nursing 28: 109–17. https://doi.org/10.1111/jcap.12113. DOI: https://doi.org/10.1111/jcap.12113

Nielsen, R. E., E. Linström, J. Nielsen, and S. Levander. 2012. “DAI-10 as Good as DAI-30 in Schizophrenia.” European Neuropsychopharmacology 22: 747–70. https://doi.org/10.1016/j.neuroeuro.2012.02.008. DOI: https://doi.org/10.1016/j.euroneuro.2012.02.008

Nunnally, J. C., and I. H. Bernstein. 1994. Psychometric Theory. 3rd ed. New York: McGraw-Hill.

O’Connor, A. M. 2002. User manual: Decision Self Efficacy Scale. Ottawa Hospital Research Institute. Accessed 15 March 2022. https://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_Decision_SelfEfficacy.pdf.

Osterberg, L., and T. Blaschke. 2005. “Adherence to Medication.” New England Journal of Medicine 353 (5): 487–97. https://doi.org/10.1056/NEJMra050100. DOI: https://doi.org/10.1056/NEJMra050100

Peat, J., and B. Barton. 2008. Medical Statistics: A Guide to Data Analysis and Critical Appraisal. New Jersey: John Wiley & Sons.

Pesut, D., S. Raskovic, S. V. Tomic, M. Bulajic, M. Bogic, B. Bursuc, and P. A. Peric. 2014. “Gender Differences Revealed by the Brief Illness Perception Questionnaire in Allergic Rhinitis.” Clinical Respiratory Journal 8 (3): 364–8. https://doi.org/10.1111/crj.12082. DOI: https://doi.org/10.1111/crj.12082

Petrie, K. J., and J. Weinman. 2012. “Patients’ Perceptions of Their Illness: The Dynamo of Volition in Health Care.” Current Directions in Psychological Science 21 (1): 60–65. https://doi.org/10.1177/0963721411429456. DOI: https://doi.org/10.1177/0963721411429456

Polanczyk, G. V., G. A. Salum, L. S. Sugaya, A. Caye, and L. A. Rohde. 2015. “Annual Research Review: A Meta-Analysis of the Worldwide Prevalence of Mental Disorders in Children and Adolescents.” Journal of Child Psychology & Psychiatry 56 (3): 345–65. https://doi.org/10.1111/jcpp.12381. DOI: https://doi.org/10.1111/jcpp.12381

Seal, F., A. J. Cave, and L. L. Atkinson. 2017. “Primary Non-Adherence of Prescribed Pharmaceutical Treatments and Interventions: An Investigative Review to Improve Quality in Primary Care.” Quality in Primary Care 25 (5): 344–59.

Semahegn, A., K. Torpey, A. Manu, N. Assefa, G. Tesfaye, and A. Ankomah. 2018. “Psychotropic Medication Non-Adherence and Associated Factors Among Adult Patients with Major Psychiatric Disorders: A Protocol for a Systematic Review.” Systematic Reviews 7 (10): 1–5. https://doi.org/10.1186/s13643-018-0676-y. DOI: https://doi.org/10.1186/s13643-018-0676-y

Stangor, C. 2015. Research Methods for the Behavioral Sciences. 5th ed. Stamford: Wadsworth Cengage Learning.

Steca, P., A. Greco, D. Monzani, A. Politi, R. Gestra, R. G. Ferrari, G. Malfatto, and G. Parati. 2013. “How Does Illness Severity Influence Depression, Health Satisfaction and Life Satisfaction in Patients with Cardiovascular Disease? The Mediating Role of Illness Perception and Self-Efficacy Beliefs.” Psychology and Health 28 (7): 765–83. https://doi.org/10.1080/08870446.2012.759223. DOI: https://doi.org/10.1080/08870446.2012.759223

Steinhausen, H. C. 2015. “Recent International Trends in Psychotropic Medication Prescriptions for Children and Adolescents.” European Child and Adolescent Psychiatry 24: 635–40. https://doi.org/10.1007/s00787-014-0631-y. DOI: https://doi.org/10.1007/s00787-014-0631-y

Taj, F., M. Tanwir, Z. Aly, A. A. Khowajah, A. Tariq, F. K. Syed, F. Waqar., and K. Shahzada. 2008. “Factors Associated with Non-Adherence Among Psychiatric Patients at a Tertiary Care Hospital, Karachi, Pakistan: A Questionnaire Based Cross-Sectional Study.” Journal of Pakistan Medical Association 58 (8): 432–6.

Tan, J. O., and J. M. Fegert. 2004. “Capacity and Competence in Child and Adolescent Psychiatry.” Health Care Analysis 12 (4): 285–94. https://doi.org/10.1007/s10728-004-6636-9. DOI: https://doi.org/10.1007/s10728-004-6636-9

Tavakol, M., and R. Dennick. 2011. “Making Sense of Cronbach’s Alpha.” International Journal of Medical Education Correspondence 2: 53–55. https://doi.org/10.5116/ijme.4dfb.8dfd. DOI: https://doi.org/10.5116/ijme.4dfb.8dfd

Thunander Sundbom, L., and K. Bingefors. 2012. “Women and Men Report Different Behaviours in and Reasons for Medication Non-Adherence: A Nationwide Swedish Survey.” Pharmacy Practice 10 (4): 207–21. DOI: https://doi.org/10.4321/S1886-36552012000400005

Timlin, U., K. Riala, and H. Kyngäs. 2013. “Adherence to Treatment among Adolescents in a Psychiatric Ward.” Journal of Clinical Nursing 22: 1332–42. https://doi.org/10.1111/jocn.12024. DOI: https://doi.org/10.1111/jocn.12024

Townsend, L., J. Floersch, and R. L. Findling. 2009. “Adolescent Attitudes toward Psychiatric Medication: The Utility of the Drug Attitude Inventory.” Journal of Child Psychology and Psychiatry 50 (12): 1523–31. https://doi.org/10.1111/j.1469-7610.2009.02113.x. DOI: https://doi.org/10.1111/j.1469-7610.2009.02113.x

Townsend, L., J. Floersch, and R. L. Findling. 2010. “The Conceptual Adequacy of the Drug Attitude Inventory for Measuring Youth Attitudes toward Psychotropic Medications: A Mixed Methods Evaluation.” Journal of Mixed Methods Research 4 (1): 32–55. https://doi.org/10.1177/1558689809352469. DOI: https://doi.org/10.1177/1558689809352469

WHO (World Health Organization). 2003. “Adherence to Long-Term Therapies: Evidence for Action.” Geneva: WHO. Accessed 6 January 2022. http://apps.who.int/iris/bitstream/handle/10665/42682/9241545992.pdf;jsessionid=BE882455CFC9CF3547E3BEE05F7F226C?sequence=1.

WHO (World Health Organization). 2013. “Comprehensive Mental Health Action Plan 2013–2020.” Geneva: WHO. Accessed 6 January 2022. http://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_R8-en.pdf?ua=1.